Efavirenz- and nevirapine-based HAART equally effective in HIV infections

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1379, 2003-01, pp. : 11-12

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Nevirapine-based HAART is more effective than protease inhibitor (PI)-based HAART in antiretroviral therapy-naive pregnant women with HIV infection

By  

Inpharma, Vol. 1, Iss. 1590, 2007-01 ,pp. : 16-16

Adis International

Access to resources Recommend Favorite

Efavirenz-based regimens more effective in HIV infections

By  

Inpharma, Vol. 1, Iss. 1405, 2003-01 ,pp. : 13-14

Adis International

Access to resources Recommend Favorite

Efavirenz + NRTIs most effective for HIV-1 infections

By  

Inpharma, Vol. 1, Iss. 1639, 2008-01 ,pp. : 1-1

Adis International

Access to resources Recommend Favorite

Efavirenz-based therapy a winner for HIV-1 infections

By  

Inpharma, Vol. 1, Iss. 1556, 2006-01 ,pp. : 11-12

Adis International

Access to resources Recommend Favorite

Morphological and Metabolic Components of Lipodystrophy in Various Nevirapine-Based Highly Active Antiretroviral Therapy (HAART) Regimens: A Cross-Sectional, Observational Study

By Guaraldi Giovanni  

Clinical Drug Investigation, Vol. 31, Iss. 11, 2011-11 ,pp. : 759-767

Adis International

Access to resources Recommend Favorite